Birgit Schultes

Company: Intellia Therapeutics

Job title: Senior Vice President, Cell Therapy

Seminars:

Unlocking Allogeneic TCR Therapies to Pursue Wider Treatment Capability 1:30 pm

Achieving a durable allogeneic response to promote tumor persistence Preventing graft versus host disease to inhibit toxicity in vivo Ensuring TCR scalability to boost off-the-shelf manufacturingRead more

day: Conference Day Two